What's new

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Feb 9, 2025 - 22:26
 0
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised
Read More

Tags:

Previous Article

Eldisine

Next Article

Non-clinical Working Party

Related Posts

PSUSA/00003148/202405

PSUSA/00003148/202405

Feb 9, 2025  0

Questions & answers - Practical arrangements on the com...

Apr 11, 2025  0

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0